600 participants
Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-24
- Start Date:
- 2026-03-18
- Completion:
- 2026-11-18
Conditions
- ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Interventions
- DRUG
No Results Yet